eli lilly tirzepatide lawsuit A class-action has been filed against CVS Caremark over its decision to stop covering Zepbound, Lilly's blockbuster GLP-1 drug to treat obesity. When the major pharmacy benefit manager informed patients Eli Lilly files 10 lawsuits

The same number of people lost coverage for Wegovy, according to an analysis by GoodRx, a drug discount website.

Posts from influencers, celebrities, and other social media users who document their GLP-1 weight loss journeys regularly go viral

Aging is the strongest risk factor for many chronic diseases, including frailty and neurodegenerative conditions

It has a long history of use in traditional Chinese medicine

Foundations at Maitland is a premier weight loss clinic in Orlando

We present the case of a 32-year-old woman with no prior medical history who developed hematochezia and abdominal pain after six weeks of tirzepatide therapy for weight loss